HR Execs on the Move


 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people`s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world`s leading independent biotechnology companies, has reached millions of patients around the world and is ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.amgen.com
  • One Amgen Center Drive
    Thousand Oaks, CA USA 91320
  • Phone: 805.447.1000

Executives

Name Title Contact Details
Dean Patras
Chief People Officer Profile
Dean P
Chief People Officer Profile
Caitlin Zinsser
VP | Talent Advisor | Corporate Functions Profile
Heidi Trybus
Senior Talent Acquisition Partner (Consultant) Profile
Tony Savens
Area Sales Director, Rare Disease Business Profile

Similar Companies

Pharmaceutical Product Development

The Pharmaceutical Product Development, LLC is a global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services.

BH1 (Better Health for Everyone)

BH1 (Better Health for Everyone) is a Franklin, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ikena Oncology

Ikena Oncology is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients.

Magnolia NeuroSciences

Magnolia Neurosciences Corporation is a drug discovery and development company focused on the creation of a novel class of neuroprotective medicines.

Xontogeny

Xontogeny is a life sciences accelerator that collaborates with entrepreneurs, scientific founders and first-time CEOs to drive the successful development of their technologies to enable new treatment options for patients with serious disease.